Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Ma KC, Surie D, Lauring AS, Martin ET, Leis AM, Papalambros L, Gaglani M, Columbus C, Gottlieb RL, Ghamande S, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Saeed S, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Hough CL, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Parikh B, Exline MC, Vaughn IA, Ramesh M, Safdar B, Mosier J, Harris ES, Shapiro NI, Felzer J, Zhu Y, Grijalva CG, Halasa N, Chappell JD, Womack KN, Rhoads JP, Baughman A, Swan SA, Johnson CA, Rice TW, Casey JD, Blair PW, Han JH, Ellington S, Lewis NM, Thornburg N, Paden CR, Atherton LJ, Self WH, Dawood FS, DeCuir J. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. Clin Infect Dis. 2026 Mar 17; 82(3):e595-e603.
-
Ihdayhid AR, Sellers SL, Polsani V, Fairbairn T, Khoo J, Fitzgibbons TP, Corrigan F, Ko B, Gooley R, Vucic E, Liu S, Coughlan F, Yong G, Shetty S, Chatfield A, Akodad M, Mohammadi A, Raju V, Lewin S, Blanke P, Kakouros N, Sathananthan J, Webb J, Wood D, Leipsic J. Feasibility and utility of anatomical and physiological evaluation of coronary artery disease with cardiac CT in severe aortic stenosis (FUTURE-AS registry). J Cardiovasc Comput Tomogr. 2026 Mar-Apr; 20(2):148-156.
-
Hoesterey DT, Dang H, Markovic D, Buhr RG, Tashkin DP, Barr RG, Belperio JA, Bowler RP, Bleecker ER, Couper DJ, Criner GJ, Cooper CB, Doerschuk CM, Dransfield MT, Drummond MB, Fawzy A, Freeman CM, Han MK, Hansel NN, Hastie AT, Hoffman EA, Huang YJ, Kaner RJ, Kanner RE, Kim V, Krishnan JA, Martinez FJ, O'Neal WK, Ortega VE, Paine R, Shrivastav AK, Wells JM, Woodruff PG, Curtis JL, Barjaktarevic I. Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort. Ann Am Thorac Soc. 2025 Dec; 22(12):1881-1890.
-
Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, D'Agostino MA, Gaffney K, Kay J, de la Loge C, Massow U, Taieb V, Vaux T, Deodhar A. Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. RMD Open. 2025 11 28; 11(4).
-
Shah N, Katragkou A, Fortin O, Tomatis Souverbielle C, Santos Oren M, Sheth A, Calardo S, Hauger SB, Angelis D, Gagliardo C, Solaiman A, Erdem G, Harik N, Mulkey SB, Downey R, Ansusinha E, Chalak L, Chiu S, Di Pentima MC, S?nchez PJ, Teran PR. Predicting Severe Short-Term Neurologic Outcomes in Human Parechovirus Meningoencephalitis. Pediatrics. 2025 Oct 01; 156(4).
-
Liesenfeld O, Arora S, Aufderheide TP, Clements CM, DeVos E, Fischer M, Giamarellos-Bourboulis EJ, House S, Humphries RL, Gill JK, Liu E, Mace SE, May L, Michelson E, Osborn TM, Panacek E, Rothman RE, Self WH, Smithline HA, Steingrub J, Van Heukelom P, Weissman A, Wilson M, Wolk DM, Wright DW, Buturovic L, Hasin-Brumshtein Y, Damaraju N, Lu C, Shak JR, Whitfield NN, Khatri P, Sweeney TE, Shapiro NI. Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis. Nat Med. 2025 Dec; 31(12):4044-4054.
-
Lebwohl M, Gooderham MJ, Warren RB, Tha?i D, Foley P, Gottlieb AB, Torres T, Popmihajlov Z, Jou YM, Linaberry M, Daamen C, Griffiths CEM. Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis. Clin Exp Dermatol. 2025 Sep 25; 50(10):2030-2036.
-
Dasan B, Munisankar S, Kumar NP, Moideen K, Pandiarajan AN, Nott S, Viswanathan V, Shanmugam S, Hissar S, Thiruvengadam K, Kornfeld H, Babu S. Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis. Front Immunol. 2025; 16:1612709.
-
Sriram S, Jensen ET, Msall ME, Yi JX, Zhabotynski V, Joseph RM, Kuban KCK, Frazier JA, Hooper SR, Santos HP, Gogcu S, Dammann C, Dammann O, Shenberger J, Fry RC, O'Shea TM. Retinopathy of Prematurity and Neurodevelopmental and Quality-of-Life Outcomes at 10 Years of Age. Am J Perinatol. 2026 Apr; 43(5):691-706.
-
Ekuban FA, Gripshover TC, Ames P, Biswas K, Bolatimi OE, Abramson J, Iyer M, Luo J, Ekuban A, Hwang JY, Park JW, Banerjee M, Watson WH, Wahlang B, Bello D, Schlezinger JJ, McClain CJ, Cave MC. Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model. Toxicol Sci. 2025 Aug 01; 206(2):388-408.